Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in Radioiodine-Refractory Thyroid Cancer
NCT00085293Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2004
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in Papillary Thyroid Carcinoma (PTC), follicular thyroid carcinoma (FTC), sponsored by National Cancer Institute. Started May 2004; status: completed.
02
Drugs
decitabine
03
Conditions
Papillary Thyroid Carcinoma (PTC)follicular thyroid carcinoma (FTC)
Beyond the preview
Go deeper on NCT00085293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085293.